Zions Bancorporation N.A. Increases Stake in HealthEquity, Inc. (NASDAQ:HQY)

Zions Bancorporation N.A. lifted its stake in HealthEquity, Inc. (NASDAQ:HQY) by 17.6% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 24,244 shares of the company’s stock after buying an additional 3,636 shares during the quarter. Zions Bancorporation N.A.’s holdings in HealthEquity were worth $2,326,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. EFG Asset Management North America Corp. increased its holdings in HealthEquity by 103.8% in the 4th quarter. EFG Asset Management North America Corp. now owns 45,647 shares of the company’s stock valued at $4,382,000 after acquiring an additional 23,247 shares during the last quarter. EntryPoint Capital LLC bought a new stake in shares of HealthEquity in the fourth quarter worth about $591,000. Summit Creek Advisors LLC boosted its stake in HealthEquity by 11.0% during the fourth quarter. Summit Creek Advisors LLC now owns 285,913 shares of the company’s stock valued at $27,433,000 after buying an additional 28,424 shares during the last quarter. Vanguard Group Inc. boosted its stake in HealthEquity by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 8,976,091 shares of the company’s stock valued at $861,256,000 after buying an additional 99,624 shares during the last quarter. Finally, LPL Financial LLC grew its holdings in HealthEquity by 11.8% during the 4th quarter. LPL Financial LLC now owns 42,256 shares of the company’s stock valued at $4,211,000 after buying an additional 4,451 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Down 0.1 %

NASDAQ:HQY opened at $90.19 on Wednesday. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market cap of $7.80 billion, a price-to-earnings ratio of 82.74, a price-to-earnings-growth ratio of 1.60 and a beta of 0.62. The stock has a fifty day simple moving average of $104.40 and a 200-day simple moving average of $95.94. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. Raymond James upgraded HealthEquity from an “outperform” rating to a “strong-buy” rating and lowered their target price for the company from $120.00 to $115.00 in a research report on Tuesday. Royal Bank of Canada boosted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a report on Tuesday, December 10th. JMP Securities increased their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. KeyCorp reduced their price objective on HealthEquity from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Monday. Finally, Wells Fargo & Company lifted their target price on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. One analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $113.31.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 2.20% of the stock is currently owned by company insiders.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.